Work

Off‐Label Use of Mycophenolate: Can Real‐World Evidence Fetch Regulatory Approval for Lupus Nephritis and Other Indications?

Year: 2024

Type: article

Abstract: The authors declared no competing interests for this work. Table S1 Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.3472

Authors: Nisha Sharma, Smita Pattanaik

Institution: Post Graduate Institute of Medical Education and Research

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4403544603

FWCI:

Cites: 7

Cited by:

Related to: 10